TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive In Brief: NCI Holding Up Regional Cooperative Group RFA Until Department Approves New Mechanism February 27, 1981